BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 14607948)

  • 1. TRANCE-RANK costimulation is required for IL-12 production and the initiation of a Th1-type response to Leishmania major infection in CD40L-deficient mice.
    Padigel UM; Kim N; Choi Y; Farrell JP
    J Immunol; 2003 Nov; 171(10):5437-41. PubMed ID: 14607948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of TNF-related activation-induced cytokine-receptor activating NF-kappa B interaction in acute allograft rejection and CD40L-independent chronic allograft rejection.
    Guillonneau C; Louvet C; Renaudin K; Heslan JM; Heslan M; Tesson L; Vignes C; Guillot C; Choi Y; Turka LA; Cuturi MC; Anegon I; Josien R
    J Immunol; 2004 Feb; 172(3):1619-29. PubMed ID: 14734743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The development of a Th1-type response and resistance to Leishmania major infection in the absence of CD40-CD40L costimulation.
    Padigel UM; Perrin PJ; Farrell JP
    J Immunol; 2001 Nov; 167(10):5874-9. PubMed ID: 11698463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of Macrophage Antigen 1 and CD40 Ligand Leads to IL-12 Production and Resistance in CD40-Deficient Mice Infected with Leishmania major.
    Okwor I; Jia P; Uzonna JE
    J Immunol; 2015 Oct; 195(7):3218-26. PubMed ID: 26304989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD40-CD40 ligand costimulation is not required for initiation and maintenance of a Th1-type response to Leishmania major infection.
    Padigel UM; Farrell JP
    Infect Immun; 2003 Mar; 71(3):1389-95. PubMed ID: 12595456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced secretion of IFN-gamma by activated Th1 cells occurs via reverse signaling through TNF-related activation-induced cytokine.
    Chen NJ; Huang MW; Hsieh SL
    J Immunol; 2001 Jan; 166(1):270-6. PubMed ID: 11123302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRANCE, a tumor necrosis factor family member critical for CD40 ligand-independent T helper cell activation.
    Bachmann MF; Wong BR; Josien R; Steinman RM; Oxenius A; Choi Y
    J Exp Med; 1999 Apr; 189(7):1025-31. PubMed ID: 10190893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cooperation of TNF family members CD40 ligand, receptor activator of NF-kappa B ligand, and TNF-alpha in the activation of dendritic cells and the expansion of viral specific CD8+ T cell memory responses in HIV-1-infected and HIV-1-uninfected individuals.
    Yu Q; Gu JX; Kovacs C; Freedman J; Thomas EK; Ostrowski MA
    J Immunol; 2003 Feb; 170(4):1797-805. PubMed ID: 12574344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disabling of receptor activator of nuclear factor-kappaB (RANK) receptor complex by novel osteoprotegerin-like peptidomimetics restores bone loss in vivo.
    Cheng X; Kinosaki M; Takami M; Choi Y; Zhang H; Murali R
    J Biol Chem; 2004 Feb; 279(9):8269-77. PubMed ID: 14679212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced effector and memory CTL responses generated by incorporation of receptor activator of NF-kappa B (RANK)/RANK ligand costimulatory molecules into dendritic cell immunogens expressing a human tumor-specific antigen.
    Wiethe C; Dittmar K; Doan T; Lindenmaier W; Tindle R
    J Immunol; 2003 Oct; 171(8):4121-30. PubMed ID: 14530334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-4-independent inhibition of IL-12 responsiveness during Leishmania amazonensis infection.
    Jones DE; Buxbaum LU; Scott P
    J Immunol; 2000 Jul; 165(1):364-72. PubMed ID: 10861073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD40 ligand is required for protective cell-mediated immunity to Leishmania major.
    Campbell KA; Ovendale PJ; Kennedy MK; Fanslow WC; Reed SG; Maliszewski CR
    Immunity; 1996 Mar; 4(3):283-9. PubMed ID: 8624818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RANK-Fc: a therapeutic antagonist for RANK-L in myeloma.
    Sordillo EM; Pearse RN
    Cancer; 2003 Feb; 97(3 Suppl):802-12. PubMed ID: 12548579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phlebotomus papatasi sand fly salivary gland lysate down-regulates a Th1, but up-regulates a Th2, response in mice infected with Leishmania major.
    Mbow ML; Bleyenberg JA; Hall LR; Titus RG
    J Immunol; 1998 Nov; 161(10):5571-7. PubMed ID: 9820534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRANCE together with IL-7 induces pre-B cells to proliferate.
    Kato I; Sato H; Kudo A
    Eur J Immunol; 2003 Feb; 33(2):334-41. PubMed ID: 12548564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BALB/c mice bearing a transgenic IL-12 receptor beta 2 gene exhibit a nonhealing phenotype to Leishmania major infection despite intact IL-12 signaling.
    Nishikomori R; Gurunathan S; Nishikomori K; Strober W
    J Immunol; 2001 Jun; 166(11):6776-83. PubMed ID: 11359836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NF-kappa B1 is required for optimal CD4+ Th1 cell development and resistance to Leishmania major.
    Artis D; Speirs K; Joyce K; Goldschmidt M; CaamaƱo J; Hunter CA; Scott P
    J Immunol; 2003 Feb; 170(4):1995-2003. PubMed ID: 12574369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TLR9-dependent activation of dendritic cells by DNA from Leishmania major favors Th1 cell development and the resolution of lesions.
    Abou Fakher FH; Rachinel N; Klimczak M; Louis J; Doyen N
    J Immunol; 2009 Feb; 182(3):1386-96. PubMed ID: 19155485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of the production of soluble IL-4 receptors in murine cutaneous leishmaniasis. The roles of IL-12 and IL-4.
    Fernandez-Botran R; Chilton PM; Hondowicz BD; Vetvickova J; Yan J; Jones W; Scott P
    J Leukoc Biol; 1999 Sep; 66(3):481-8. PubMed ID: 10496319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.
    Padigel UM; Farrell JP
    J Immunol; 2005 May; 174(10):6340-5. PubMed ID: 15879134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.